TIGIT and neoplasm: A recently described inhibitory receptor, TIGIT, known to inhibit the function of T cells and NK cells17, 18, 19, is expressed on the majority of HIV-specific CD8+ T cells23 and tumor-infiltrating lymphocytes21, 22.